Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 162318-34-5, molcular formula is C12H8N2, introducing its new discovery. HPLC of Formula: C12H8N2
A containing [2P2N] cu (I) iron-iron hydrogenase models of the photosensitizer and methods of producing the same (by machine translation)
A containing [2P2N] cu (I) iron-iron hydrogenase model of the photosensitizer, containing [2Fe2S] and catalytic centre [2P2N] cu (I) photosensitizer, through one of the two and bipyridyl ligands containing isonitriles conjugate bridge is connected with use. This kind of model a chemical structural formula shown below: In the structural formula of the bisphosphine ligands include 1, 3-bis (mortars; concrete ; artificial stone) propane (dppp); cis -1, 2-bis (mortars; concrete ; artificial stone) ethylene (dppv); double (2-bis-phenyl phosphorus phenyl) ether (POP); 1, 1 ?-bis (mortars; concrete ; artificial stone) ferrocene (dppf); 1, 2-bis (mortars; concrete ; artificial stone) benzene (dppb). The beneficial results of this invention are: simple preparation process, the raw material is cheap and easy to obtain, mild reaction conditions, high yield; can be prepared by changing the bisphosphine ligands containing more [2P2N] cu (I) iron-iron hydrogenase models object of the photosensitizer. (by machine translation)
One of the oldest and most widely used commercial enzyme inhibitors is aspirin, HPLC of Formula: C12H8N2, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 162318-34-5
Reference：
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI